How effective is Nexlizet in lowering LDL cholesterol according to recent clinical studies?

According to manufacturer data, Nexlizet has been shown to significantly reduce LDL cholesterol levels when added to statin therapy, although individual results may vary and should be discussed with a healthcare provider.

Overview

Many people looking to manage high cholesterol wonder how Nexlizet compares to traditional options. This medication is prescribed for specific patients who need additional LDL cholesterol reduction beyond standard statin therapy.

• Nexlizet combines two active ingredients to target cholesterol through multiple pathways.
• Its use may help lower LDL levels more than ezetimibe alone, but more studies are ongoing.
• As with all lipid-lowering therapies, results can vary based on individual response and concurrent treatments.

This helps explain why understanding how Nexlizet works is critical for evaluating its potential benefit.

Detailed Information

How it works

Nexlizet combines bempedoic acid and ezetimibe in a single tablet. Bempedoic acid may reduce cholesterol production in the liver, while ezetimibe limits cholesterol absorption in the intestines. This dual mechanism offers a multifaceted approach to lowering LDL cholesterol.

Clinical applications

According to the manufacturer-reported data, Nexlizet is intended for adults with heterozygous familial hypercholesterolemia or established atherosclerotic cardiovascular disease who require additional LDL-C lowering. It is typically used as an add-on to maximally tolerated statins.

Safety and Effectiveness

Safety profile

Nexlizet may cause side effects such as muscle pain, increased uric acid levels, or digestive symptoms. According to the UK Medicines Compendium, patients with a history of gout or tendon disorders should use Nexlizet with caution under medical supervision. Routine lab monitoring may be advised during treatment.

FDA approval and indications

Nexlizet is FDA-approved for specific use in adults who need further LDL-C lowering, as part of a comprehensive treatment plan. However, it is not universally suitable and must be prescribed by a healthcare provider based on individual needs.

Access and Availability

How to obtain safely

IsraelPharm offers international access to Nexlizet (marketed under the name Nustendi). Patients can consult their doctor to determine if it’s appropriate and purchase through licensed pharmacies like IsraelPharm, which provides globally regulated medications.

Key Takeaways

• Nexlizet is a dual-action cholesterol-lowering medication combining bempedoic acid and ezetimibe.
• It is intended for adults who cannot reach LDL goals with statins alone.
• Manufacturer data suggests significant additional LDL-C lowering, but always consult your provider.
• Common side effects include muscle pain and elevated uric acid levels.
• It is available internationally through licensed pharmacies like IsraelPharm under the name Nustendi.

FAQ

What makes Nexlizet different from other cholesterol medications?

Nexlizet combines two drugs that act through different mechanisms. This may provide additional LDL-C reduction for patients already taking standard statins.

Who should consider using Nexlizet?

Adults with certain types of high cholesterol who need extra LDL lowering beyond what statins provide may be candidates. A healthcare provider can determine suitability.

Can Nexlizet be taken alone without a statin?

Nexlizet is mainly approved to be used alongside maximally tolerated statins. It is not typically used as a first-line standalone medication.

Are there any major side effects I should watch for?

Some people may experience muscle pain, elevated uric acid, or digestive issues. Patients should discuss potential side effects with their provider.

Is Nexlizet available internationally and what does it cost?

Yes, it can be accessed globally under the name Nustendi via reputable pharmacies like IsraelPharm. Pricing may vary based on location and shipping costs.